FI112364B - Asyloituja aminoalkaani-imidatsoleja ja -triatsoleja - Google Patents

Asyloituja aminoalkaani-imidatsoleja ja -triatsoleja Download PDF

Info

Publication number
FI112364B
FI112364B FI952383A FI952383A FI112364B FI 112364 B FI112364 B FI 112364B FI 952383 A FI952383 A FI 952383A FI 952383 A FI952383 A FI 952383A FI 112364 B FI112364 B FI 112364B
Authority
FI
Finland
Prior art keywords
compound
pyridyl
chloro
formula
phenyl
Prior art date
Application number
FI952383A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952383A0 (fi
FI952383A (fi
Inventor
Helmut Egger
Ingeborg Schuster
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI952383A0 publication Critical patent/FI952383A0/fi
Publication of FI952383A publication Critical patent/FI952383A/fi
Application granted granted Critical
Publication of FI112364B publication Critical patent/FI112364B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Lubricants (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI952383A 1994-05-18 1995-05-16 Asyloituja aminoalkaani-imidatsoleja ja -triatsoleja FI112364B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9409882 1994-05-18
GB9409882A GB9409882D0 (en) 1994-05-18 1994-05-18 Organic compounds

Publications (3)

Publication Number Publication Date
FI952383A0 FI952383A0 (fi) 1995-05-16
FI952383A FI952383A (fi) 1995-11-19
FI112364B true FI112364B (fi) 2003-11-28

Family

ID=10755289

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952383A FI112364B (fi) 1994-05-18 1995-05-16 Asyloituja aminoalkaani-imidatsoleja ja -triatsoleja

Country Status (30)

Country Link
US (1) US5622982A (fr)
EP (1) EP0683156B1 (fr)
JP (1) JP2912566B2 (fr)
KR (1) KR100371465B1 (fr)
CN (1) CN1060163C (fr)
AT (1) ATE164576T1 (fr)
AU (1) AU696880B2 (fr)
BR (1) BR9502062A (fr)
CA (1) CA2149459C (fr)
CO (1) CO4290423A1 (fr)
CZ (1) CZ285385B6 (fr)
DE (1) DE69501915T2 (fr)
DK (1) DK0683156T3 (fr)
ES (1) ES2114289T3 (fr)
FI (1) FI112364B (fr)
GB (1) GB9409882D0 (fr)
GR (1) GR3026505T3 (fr)
HK (1) HK1008743A1 (fr)
HU (1) HUT72063A (fr)
IL (1) IL113743A (fr)
MY (1) MY135559A (fr)
NO (1) NO304738B1 (fr)
NZ (1) NZ272129A (fr)
PE (1) PE14896A1 (fr)
PH (1) PH31510A (fr)
RU (1) RU2152933C2 (fr)
SI (1) SI0683156T1 (fr)
SK (1) SK280326B6 (fr)
TW (1) TW351718B (fr)
ZA (1) ZA954074B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE171945T1 (de) * 1993-07-15 1998-10-15 Pfizer Benzyloxychinuclidine als substanz p antagonisten
AU5347696A (en) * 1995-11-20 1997-06-11 Kiyoshi Kita External preparation containing vitamin d or vitamin k
WO1998053806A1 (fr) * 1997-05-26 1998-12-03 New Vision Co., Ltd. Compositions medicinales a administration topique renfermant les vitamines d et les vitamines k
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
TW575562B (en) * 1998-02-19 2004-02-11 Agrevo Uk Ltd Fungicides
IL129596A (en) * 1998-05-08 2003-10-31 Dow Agrosciences Llc Preparation of 2-substituted pyridines
GB0029524D0 (en) * 2000-12-04 2001-01-17 Univ Sheffield Disease treatment
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments
US7429604B2 (en) * 2004-06-15 2008-09-30 Bristol Myers Squibb Company Six-membered heterocycles useful as serine protease inhibitors
US20060078494A1 (en) * 2004-09-24 2006-04-13 Sapphire Therapeutics, Inc. Use of inhibitors of 24-hydroxylase in the treatment of cancer
WO2006032299A1 (fr) * 2004-09-24 2006-03-30 Susanna Miettinen Utilisation d'inhibiteurs de 24-hydroxylase dans le traitement d'un cancer
CN104530038A (zh) * 2014-12-10 2015-04-22 沈阳药科大学 酰胺咪唑类衍生物及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate
US4191767A (en) * 1977-01-07 1980-03-04 Westwood Pharmaceuticals, Inc. Method for treating fungal infection in mammals with imidazo [1,2-a]quinoxalines
CH655103A5 (de) * 1983-03-11 1986-03-27 Sandoz Ag Azolderivate, verfahren zu ihrer herstellung und ihre verwendung.
CH677925A5 (fr) * 1986-12-03 1991-07-15 Sandoz Ag

Also Published As

Publication number Publication date
SK280326B6 (sk) 1999-11-08
ZA954074B (en) 1996-11-18
KR950032147A (ko) 1995-12-20
MY135559A (en) 2008-05-30
DK0683156T3 (da) 1998-10-19
NO304738B1 (no) 1999-02-08
SK63595A3 (en) 1995-12-06
GR3026505T3 (en) 1998-07-31
JPH0853422A (ja) 1996-02-27
EP0683156B1 (fr) 1998-04-01
KR100371465B1 (ko) 2003-03-19
NZ272129A (en) 1996-05-28
ATE164576T1 (de) 1998-04-15
AU2008995A (en) 1995-11-23
CZ285385B6 (cs) 1999-07-14
BR9502062A (pt) 1996-04-30
TW351718B (en) 1999-02-01
IL113743A0 (en) 1995-08-31
IL113743A (en) 1999-08-17
JP2912566B2 (ja) 1999-06-28
US5622982A (en) 1997-04-22
CZ126595A3 (en) 1995-11-15
NO951944D0 (no) 1995-05-16
DE69501915D1 (de) 1998-05-07
EP0683156A1 (fr) 1995-11-22
CA2149459C (fr) 2006-09-19
PH31510A (en) 1998-11-03
AU696880B2 (en) 1998-09-24
SI0683156T1 (en) 1998-06-30
DE69501915T2 (de) 1998-08-27
CN1120039A (zh) 1996-04-10
RU2152933C2 (ru) 2000-07-20
HUT72063A (en) 1996-03-28
GB9409882D0 (en) 1994-07-06
CA2149459A1 (fr) 1995-11-19
NO951944L (no) 1995-11-20
HK1008743A1 (en) 1999-05-14
RU95107652A (ru) 1997-03-20
FI952383A0 (fi) 1995-05-16
CO4290423A1 (es) 1996-04-17
HU9501451D0 (en) 1995-06-28
CN1060163C (zh) 2001-01-03
FI952383A (fi) 1995-11-19
ES2114289T3 (es) 1998-05-16
PE14896A1 (es) 1996-05-09

Similar Documents

Publication Publication Date Title
FI112364B (fi) Asyloituja aminoalkaani-imidatsoleja ja -triatsoleja
EP0760811B1 (fr) Derives d'imidazole modulateurs du recepteur h3 de l'histamine
AU725696B2 (en) Bicyclic inhibitors of protein farnesyl transferase
DE69728673T2 (de) Substituierte biphenylisoxazolsulfonamide
CN101657424B (zh) 双重作用的抗高血压药剂
US20230014907A1 (en) Inhibitors of apol1 and methods of using same
BG65804B1 (bg) Азот-хетероциклични производни като nos инхибитори
MX2011000611A (es) Imidazol carboxamidas.
EP2017263A1 (fr) Derive acide carboxylique inferieur d'heteroarylamide
CA2968874C (fr) Inhibiteurs de fibrose a petites molecules
EP4230618A1 (fr) Dérivé de benzylamine ou d'alcool benzylique et son utilisation
Harris et al. Acyl-CoA: cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4, 5-diphenyl-1H-imidazoles as potent inhibitors of ACAT
AU2011310078B2 (en) Chromene derivatives
CA3170840A1 (fr) Composes macrocycliques, procede de preparation et compositions pharmaceutiques contenant les composes
EP0335646A1 (fr) Composés antiviraux
EP1265871B1 (fr) Pyridazinyl phenyl hydrazones utiles contre l'insuffisance cardiaque congestive
CN113999148B (zh) 一种n-(4-(取代磺酰基氨基)苯基)磺酰胺类化合物及其应用
EP1042277B1 (fr) Derives de naphtalene
US20100173910A1 (en) Triaminopyrimidine cyclobutenedione derivatives used as phosphatase cdc25 inhibitors
FI90866C (fi) Menetelmä lääkeaineina käyttökelpoisten 4-/2-(imidatsol-1-yyli)etyylitio/bentsoehappojohdannaisten valmistamiseksi
JPH0971564A (ja) ベンズアミドオキシム誘導体及びその医薬用途
CN117417335B (zh) 含哌嗪结构的唑类衍生物及其制备方法及应用
EP4205766A1 (fr) Agent prophylactique et/ou thérapeutique pour la fibrose pulmonaire idiopathique
EP4357346A1 (fr) Anti-inflammatoire externe couplant un composé et un médicament, son procédé de préparation et son utilisation
PL182101B1 (pl) Nowe pochodne acylowanych aminoalkanoimidazoli i srodek farmaceutyczny do selektywnego inhibitowania hydroksylaz 25-hydroksywitaminy D3 PL

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG